Multinational pharmaceutical companies seem to avoid entering into domestic market

Recently, according to industry official related to clinical trial, it was analyzed that domestic clinical trial has joined the ranks of advanced countries, but clinical trial may not activated as it used to be. The reason is low level health insurance benefit. As the insurance benefit was so cheaply priced, multinational pharmaceutical companies do not feel the need for Korea market, so theref...